Search results for " QoL"

showing 5 items of 5 documents

Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group

2017

Fabry disease (FD) [OMIM 301500] is an X-linked lysosomal storage disorder caused by a deficiency of the lysosomal enzyme alpha-galactosidase A, resulting in progressive multisystem accumulation of globotriaosylceramide (Gb3). Although the introduction of Enzyme Replacement Therapy (ERT) resulted in a variety of clinical benefits, life-long intravenous (IV) treatment with ERT with an every other week schedule, may interfere with daily life activities and impact on QoL. We report here a multicentric, observational, longitudinal data analysis on a large cohort of 85 Italian FD patients (45 males, 40 females) from 11 out of 20 Italian regions, who received a cumulative number of 4269 home infu…

0301 basic medicinePediatricsmedicine.medical_specialtyQoLGlobotriaosylceramide03 medical and health scienceschemistry.chemical_compoundCollaborative group0302 clinical medicineEndocrinologyDisease severityGeneticGeneticsMedicine030212 general & internal medicinelcsh:QH301-705.5Molecular Biologylcsh:R5-920Fabry diseasebusiness.industrySettore BIO/14Home treatmentEnzyme replacement therapyAdherence; Enzyme replacement therapy; Fabry disease; Home treatment; QoLmedicine.diseaseFabry disease3. Good health030104 developmental biologylcsh:Biology (General)chemistryAdherenceEnzyme replacement therapyCohortarticle;congenital malformation; Fabry disease; enzyme replacement therapy; home treatment ; adherence; QoLObservational studyHome treatmentlcsh:Medicine (General)businessResearch Paper
researchProduct

Clinical and Functional Outcome After Abdominal Wall Incisional Hernia Repair: Evaluation of Quality-of-Life Improvement and Comparison of Assessment…

2019

Background Hernias severely impact patient quality of life (QoL), and 80% of patients need surgical operation. The primary outcome of the study is to assess improvements in balance, posture and deambulation after abdominal hernia repair. Moreover, the study investigated the improvement in the postoperative QoL. Methods Patients operated at the Policlinico “Paolo Giaccone” at Palermo University Hospital between June 2015 and June 2017 were identified in a prospective database. The functional outcome measures and QoL assessment scales used were numeric rating scale for pain, performance-oriented mobility assessment (POMA) scale, Quebec back pain disability scale, center of gravity (barycenter…

AdultMalemedicine.medical_specialtyPsychometricsAbdominal Hernia030230 surgeryAbdominal wall03 medical and health sciences0302 clinical medicineQuality of lifeBack painNumeric Rating ScaleMedicineHumansIncisional HerniaHerniaPostoperative PeriodProspective StudiesProspective cohort studyHerniorrhaphyAgedPain Measurementbusiness.industryAbdominal WallQuebecAbdominal wall incisional hernia repair Qol posture barycenter deambulationRecovery of FunctionMiddle AgedSurgical Meshmedicine.diseaseHealth SurveysHernia Ventralmedicine.anatomical_structureTreatment Outcome030220 oncology & carcinogenesisPhysical therapyQuality of LifeSurgeryFemalemedicine.symptombusinessAbdominal surgeryWorld journal of surgery
researchProduct

Non-infectious uveitis burden on quality of life and work impairment assessed through different psychometric questionnaires

2021

Background: The purpose of this study was to evaluate the association between a novel psychometric 12-item questionnaire (U-qest) and other validated questionnaires to assess quality of life and work impairment in patients with non-infectious uveitis. Methods: Data were collected at baseline and 3 months postbaseline using U-qest and two other validated questionnaires: The National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25) and the 12-Item Short-Form Health Survey (SF-12). Results: A total of 136 patients (52.2% female) aged 47.9 ± 14.8 years (mean ± SD) were enrolled in 14 uveitis referral centres. U-qest correlated moderately with VFQ-25 and SF-12 at baseline and at 3 mo…

Malemedicine.medical_specialtyQoLPsychometricsReferralVisual Acuityuveitis questionnaire; QoL; disease burden; work impairmentDiseaseAffect (psychology)Uveitisdisease burdenInfectious uveitisQuality of lifeCronbach's alphawork impairmentSurveys and QuestionnairesmedicineHumansDisease burdenbusiness.industryReproducibility of ResultsGeneral Medicinemedicine.diseaseOphthalmologyQoL; Uveitis questionnaire; disease burden; work impairmentQuality of LifePhysical therapydisease burden QoL Uveitis questionnaire work impairmentFemalebusinessUveitis questionnaireUveitisuveitis questionnaire
researchProduct

A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and…

2023

Patients surviving head and neck cancer (HNC) suffer from high physical, psychological, and socioeconomic burdens. Achieving cancer-free survival with an optimal quality of life (QoL) is the primary goal for HNC patient management. So, maintaining lifelong surveillance is critical. An ambitious goal would be to carry this out through the advanced analysis of environmental, emotional, and behavioral data unobtrusively collected from mobile devices. The aim of this clinical trial is to reduce, with non-invasive tools (i.e., patients' mobile devices), the proportion of HNC survivors (i.e., having completed their curative treatment from 3 months to 10 years) experiencing a clinically relevant r…

Settore M-PSI/01 - Psicologia GeneraleBD4QoL; QOL; android; head and neck cancer; mHealth; survivorship; unobtrusiveQOLmHealthSettore MED/06 - Oncologia Medicahead and neck cancerBD4QoLandroidunobtrusivesurvivorshipFrontiers in Oncology
researchProduct

Improvement of quality of life during treatment with anabolic therapy: Results of a multicenter study

2012

Efficacy and safety of daily treatment with parathyroid hormone were evaluated in a typical Italian population with severe post-menopausal osteoporosis eligible to anabolic treatment (Nota 79 AIFA). Materials and methods: 204 ambulatory female patients (median age: 72.6±8.3 years; height: 155.3±6.5 cm; weight: 61.1±11.9 Kg) with severe post-menopausal osteoporosis have been enrolled in this study accordingly to summary of product characteristics and Italian reimbursement criteria for osteoporosis drugs (Nota 79 AIFA), between January 2008 and April 2009 (Last Patient Out: October 2010). 146 (71.57%) out of these patients completed the study.6 visits were planned in the study protocol: basel…

medicine.medical_specialtyHistologyAnabolismosteoporosis PTH Qualeffo QolPhysiologybusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaEndocrinology Diabetes and MetabolismQuality of life (healthcare)Multicenter studymedicineIntensive care medicinebusinessBone
researchProduct